Multiplex imaging and cellular target identification of kinase inhibitors via an affinity-based proteome profiling approach

Scientific Reports

Volumn 5, Issue , 2015, Pages

  Su, Ying ^a   Pan, Sijun ^a   Li, Zhengqiu ^a   Li, Lin ^a   Wu, Xiaoyuan ^a   Hao, Piliang ^b   Sze, Siu Kwan ^b   Yao, Shao Q ^a  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^b NANYANG TECHNOLOGICAL UNIVERSITY   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

MOLECULAR PROBE; PROTEIN KINASE INHIBITOR; PROTEOME;

AFFINITY CHROMATOGRAPHY; CHEMISTRY; HELA CELL LINE; HUMAN; LIQUID CHROMATOGRAPHY; METABOLISM; MOLECULAR IMAGING; MOLECULAR PROBE; MOLECULARLY TARGETED THERAPY; PROCEDURES; PROTEOMICS; TANDEM MASS SPECTROMETRY;

CHROMATOGRAPHY, AFFINITY; CHROMATOGRAPHY, LIQUID; HELA CELLS; HUMANS; MOLECULAR IMAGING; MOLECULAR PROBES; MOLECULAR TARGETED THERAPY; PROTEIN KINASE INHIBITORS; PROTEOME; PROTEOMICS; TANDEM MASS SPECTROMETRY;

EID: 84923106733     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep07724     Document Type: Article

References (56)

1. Carmena, M., Ruchaud, S. & Earnshaw, W. C. Making the Auroras glow: regulation of Aurora A and B kinase function by interacting proteins. Curr. Opin. Cell Biol. 21, 796-805 (2009).
2. Keen, N. & Taylor, S. Aurora-kinase inhibitors as anticancer agents. Nat. Rev. Cancer 4, 927-936 (2004).
3. Barr, A. R. & Gergely, F. Aurora-A: the maker and breaker of spindle poles. J. Cell Sci. 120, 2987-2996 (2007).
4. Cheung, C. H. A., Sarvagalla, S., Lee, J. Y.-C., Huang, Y.-C. & Coumar, M. S. Aurora kinase inhibitor patents and agents in clinical testing: an update (2011-2013). Expert Opin. Ther. Pat. 24, 1021-1038 (2013).
5. Harrington, E. A. et al. VX-680, a potent and selective small-molecule inhibitor of the Aurora kinases, suppresses tumor growth in vivo. Nat. Med. 10, 262-267 (2004).
6. Carter, T. A. et al. Inhibition of drug-resistant mutants of ABL, KIT, and EGF receptor kinases. Proc. Natl. Acad. Sci. 102, 11011-11016 (2005).
7. Manfredi, M. G. et al. Antitumor activity of MLN8054, an orally active smallmolecule inhibitor of Aurora A kinase. Proc. Natl. Acad. Sci. 104, 4106-4111 (2007).
8. Perez Fidalgo, J. A., Roda, D., Rosello, S., Rodriguez-Braun, E. & Cervantes, A. Aurora kinase inhibitors: a new class of drugs targeting the regulatory mitotic system. Clin. Transl. Oncol. 11, 787-798 (2009).
9. Manfredi, M. G. et al. Characterization of Alisertib (MLN8237), an investigational small-molecule inhibitor of Aurora A kinase using novel in vivo pharmacodynamic assays. Clin. Cancer Res. 17, 7614-7624 (2011).
10. Capdeville, R., Buchdunger, E., Zimmermann, J. & Matter, A. Glivec (ST1571, Imatinib), a rationally developed, targeted anticancer drug. Nat. Rev. Drug Disc. 1, 493-502 (2002).
11. Rix, U. & Superti-Furga, G. Target profiling of small molecules by chemical proteomics. Nat. Chem. Biol. 5, 616-624 (2009).
12. Anastassiadis, T., Deacon, S. W., Devarajan, K., Ma, H. & Peterson, J. R. Comprehensive assay of kinase catalytic activity reveals features of kinase inhibitor selectivity. Nat. Biotechnol. 29, 1039-1045 (2011).
13. Davis, M. I. et al. Comprehensive analysis of kinase inhibitor selectivity. Nat. Biotechnol. 29, 1046-1051 (2011).
14. Ziegler, S., Pries, V., Hedberg, C. &Waldmann, H. Target identification for small bioactive molecules: finding the needle in the haystack. Angew. Chem. Int. Ed. 52, 2744-2792 (2013).
15. Su, Y. et al. Target identification of biologically active small molecules via in situ methods. Curr. Opin. Chem.l Biol. 17, 768-775 (2013).
16. Andrews, S. S., Hill, Z. B., Perera, B. G. K. & Maly, D. J. Label transfer reagents to probe p38 MAPK binding partners. ChemBiochem 14, 209-216 (2013).
17. Yang, P.-Y. et al. Activity-based proteome profiling of potential cellular targets of Orlistat-an FDA-approved drug with anti-tumor activities. J. Am. Chem. Soc. 132, 656-666 (2010).
18. Yang, P.-Y. et al. Chemical modification and organelle-specific localization of Orlistat-like natural-product-based probes. Chem.-Asian. J. 6, 2762-2775 (2011).
19. Nasheri, N. et al.Modulation of fatty acid synthase enzyme activity and expression during Hepatitis C virus replication. Chem. Biol. 20, 570-582 (2013).
20. Rusch, M. et al. Identification of acyl protein thioesterases 1 and 2 as the cellular targets of the Ras-signaling modulators Palmostatin B and M. Angew. Chem. Int. Ed. 50, 9838-9842 (2011).
21. Pitscheider, M., Maeusbacher, N. & Sieber, S. A. Antibiotic activity and target discovery of three-membered natural product-derived heterocycles in pathogenic bacteria. Chem. Sci. 3, 2035-2041 (2012).
22. Lanning, B. R. et al. A road map to evaluate the proteome-wide selectivity of covalent kinase inhibitors. Nat. Chem. Biol. 10, 760-767 (2014).
23. Ranjitkar, P. et al. Affinity-based probes based on type II kinase inhibitors. J. Am. Chem. Soc. 134, 19017-19025 (2012).
24. Krishnamurty, R. et al. Active site profiling reveals coupling between domains in SRC-family kinases. Nat. Chem. Biol. 9, 43-50 (2013).
25. Shi, H., Zhang, C.-J., Chen, G. Y. J. & Yao, S. Q. Cell-based proteome profiling of potential Dasatinib targets by use of affinity-based probes. J. Am. Chem. Soc. 134, 3001-3014 (2012).
26. Shi, H., Cheng, X., Sze, S. K. & Yao, S. Q. Proteome profiling reveals potential cellular targets of staurosporine using a clickable cell-permeable probe. Chem. Commun. 47, 11306-11308 (2011).
27. Li, Z. et al. Design and synthesis of minimalist terminal alkyne-containing diazirine photo-crosslinkers and their incorporation into kinase inhibitors for cell-and tissue-based proteome profiling. Angew. Chem. Int. Ed. 52, 8551-8556 (2013).
28. Li, Z. et al. "Minimalist" cyclopropene-containing photo-cross-linkers suitable for live-cell imaging and affinity-based protein labeling. J. Am. Chem. Soc. 136, 9990-9998 (2014).
29. Leslie, B. J. & Hergenrother, P. J. Identification of the cellular targets of bioactive small organic molecules using affinity reagents. Chem. Soc. Rev. 37, 1347-1360 (2008).
30. Das, J. Aliphatic diazirines as photoaffinity probes for proteins: recent developments. Chem. Rev. 111, 4405-4417 (2011).
31. Baruch, A., Jeffery, D. A.&Bogyo, M. Enzyme activity-it's all about image. Trends Cell Biol. 14, 29-35 (2004).
32. Yang, K. S., Budin, G., Reiner, T., Vinegoni, C. & Weissleder, R. Bioorthogonal imaging of Aurora kinase A in live cells. Angew. Chem. Int. Ed. 51, 6598-6603 (2012).
33. Sloane, D. A. et al. Drug-resistant Aurora A mutants for cellular target validation of the small molecule kinase inhibitors MLN8054 and MLN8237. ACS Chem. Biol. 5, 563-576 (2010).
34. Sletten, E. M. & Bertozzi, C. R. Bioorthogonal chemistry: fishing for selectivity in a sea of functionality. Angew. Chem. Int. Ed. 48, 6974-6998 (2009).
35. Kalesh, K. A., Shi,H., Ge, J. &Yao, S. Q. The use of click chemistry in the emerging field of catalomics. Org. Biomol. Chem. 8, 1749-1762 (2010).
36. Chiang, C.-C. et al. Discovery of pyrrole-indoline-2-ones as Aurora kinase inhibitors with a different inhibition profile. J. Med. Chem. 53, 5929-5941 (2010).
37. Debets, M. F., van Hest, J. C. M. & Rutjes, F. P. J. T. Bioorthogonal labelling of biomolecules: new functional handles and ligation methods. Org. Biomol. Chem. 11, 6439-6455 (2013).
38. Lang, K. & Chin, J. W. Bioorthogonal reactions for labeling proteins. ACS Chem. Biol. 9, 16-20 (2014).
39. Kulms, D. et al. Nuclear and cell membrane effects contribute independently to the induction of apoptosis in human cells exposed to UVB radiation. Proc. Natl. Acad. Sci. 96, 7974-7979 (1999).
40. Kvam, E.&Tyrrell, R. M. Induction of oxidativeDNAbase damage in human skin cells by UV and near visible radiation. Carcinogenesis 18, 2379-2384 (1997).
41. Uttamapinant, C. et al. Fast, cell-compatible click chemistry with copperchelating azides for biomolecular labeling. Angew. Chem. Int. Ed. 51, 5852-5856 (2012).
42. Besanceney-Webler, C. et al. Increasing the efficacy of bioorthogonal click reactions for bioconjugation: a comparative study. Angew. Chem. Int. Ed. 50, 8051-8056 (2011).
43. Hong, V., Presolski, S. I., Ma, C. & Finn, M. G. Analysis and optimization of copper-catalyzed azide-alkyne cycloaddition for bioconjugation. Angew. Chem. Int. Ed. 48, 9879-9883 (2009).
44. Fernandez-Suarez, M. & Ting, A. Y. Fluorescent probes for super-resolution imaging in living cells. Nat. Rev. Mol. Cell Biol. 9, 929-943 (2008).
45. Edgington, L. E., Verdoes, M.&Bogyo, M. Functional imaging of proteases: recent advances in the design and application of substrate-based and activity-based probes. Curr. Opin. Chem.l Biol. 15, 798-805 (2011).
46. Carnero, A. Targeting the cell cycle for cancer therapy. Br. J. Cancer 87, 129-133 (2002).
47. Lens, S. M. A., Voest, E. E. & Medema, R. H. Shared and separate functions of polo-like kinases and aurora kinases in cancer. Nat. Rev. Cancer 10, 825-841 (2010).
48. Van Horn, R. D. et al. Cdk1 activity is required for mitotic activation of Aurora A during G(2)/M transition of human cells. J. Biol. Chem. 285, 21849-21857 (2010).
49. Huang, B., Bates, M. & Zhuang, X. Super resolution fluorescence microscopy. Annu. Rev. Biochem. 78, 993-1016 (2009).
50. Wallrabe, H. & Periasamy, A. Imaging protein molecules using FRET and FLIM microscopy. Curr. Opin. Biotechnol. 16, 19-27 (2005).
51. Krogan, N. J. et al. Global landscape of protein complexes in the yeast Saccharomyces cerevisiae. Nature 440, 637-643 (2006).
52. Mellacheruvu, D. et al. The CRAPome: a contaminant repository for affinity purification-mass spectrometry data. Nat. Methods 10, 730-736 (2013).
53. Chuang, C., Pan, J., Hawke, D. H., Lin, S.-H. & Yu-Lee, L.-y. NudC deacetylation regulates mitotic progression. Plos One 8, e73841 (2013).
54. Zhou, T., Aumais, J. P., Liu, X. Q., Yu-Lee, L. Y. & Erikson, R. L. A role for Plk1 phosphorylation of NudC in cytokinesis. Dev. Cell 5, 127-138 (2003).
55. Nishino, M. et al. NudC is required for Plk1 targeting to the kinetochore and chromosome congression. Curr. Biol. 16, 1414-1421 (2006).
56. Cisar, J. S. & Cravatt, B. F. Fully functionalized small-molecule probes for integrated phenotypic screening and target identification. J. Am. Chem. Soc. 134, 10385-10388 (2012).